封面
市场调查报告书
商品编码
1698158

乳糖不耐症市场-全球产业规模、份额、趋势、机会与预测,按类型、诊断、地区和竞争细分,2020-2030 年

Lactose Intolerance Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Diagnosis, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球乳糖不耐症市场价值为 209 亿美元,预计在预测期内将呈现令人印象深刻的成长,到 2030 年的复合年增长率为 6.70%。近年来,全球乳糖不耐症市场经历了显着的成长和演变,这得益于全球乳糖不耐症盛行率的上升以及消费者对此病症的认识的提高。乳糖不耐症是一种消化系统疾病,其特征是身体无法消化乳糖(乳製品中的糖),导致腹痛、腹泻和腹胀等症状。

市场概览
预测期 2026-2030
2024年市场规模 209亿美元
2030年市场规模 309.1亿美元
2025-2030 年复合年增长率 6.70%
成长最快的领域 原发性乳糖不耐症
最大的市场 北美洲

因此,对无乳糖和无乳製品(包括牛奶替代品、优格和起司替代品)的需求不断增长,推动了乳糖不耐症市场的发展。该市场的主要驱动因素之一是乳糖不耐症的盛行率不断上升,虽然各地区情况不同,但估计会影响全球相当一部分人口。遗传、种族和饮食习惯等因素导致了不同的盛行率。因此,人们越来越需要透过诊断测试来准确识别乳糖不耐症,同时对乳糖酶补充剂的需求也激增,这有助于乳糖不耐症患者更舒适地消化乳製品。除了乳糖不耐症盛行率不断上升之外,饮食偏好的改变以及素食主义和植物性饮食趋势的日益增长,进一步刺激了对无乳糖替代品的需求。这促使食品和饮料製造商投资研发,创造适合乳糖不耐症患者的创新乳製品替代品,进而扩大乳糖不耐症市场。此外,人们对乳糖不耐症的认识和教育不断提高,鼓励人们寻找合适的饮食选择,导致无乳糖产品的消费量激增。因此,乳糖不耐症市场见证了老牌企业和新兴公司在产品开发、行销和分销方面的大量投资。

关键市场驱动因素

乳糖不耐症盛行率上升

主要市场挑战

诊断和认知有限

主要市场趋势

植物性饮食和纯素食主义

目录

第 1 章:产品概述

第二章:研究方法

第三章:执行摘要

第四章:顾客之声

第五章:乳糖不耐症市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依类型(原发性、继发性、先天性、发育性)
    • 透过诊断(氢呼气试验、血糖试验、粪便酸度试验)
    • 按地区
    • 按公司分类(2024)
  • 市场地图

第六章:北美乳糖不耐症市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美:国家分析
    • 加拿大
    • 墨西哥

第七章:欧洲乳糖不耐症市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲:国家分析
    • 英国
    • 义大利
    • 法国
    • 西班牙

第八章:亚太乳糖不耐症市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区:国家分析
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章:南美乳糖不耐症市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲:国家分析
    • 阿根廷
    • 哥伦比亚

第十章:中东与非洲乳糖不耐症市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA:国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章:市场动态

  • 驱动程式
  • 挑战

第 12 章:市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章:全球乳糖不耐症市场:SWOT 分析

第 14 章:竞争格局

  • Kshipra Biotech Private Limited
  • EMD Serono
  • Intoleran
  • MACLEODS
  • Merck KGaA
  • DSM
  • Johnson & Johnson Services, Inc
  • NOW Foods
  • Procter & Gamble
  • Chr. Hansen Holding A/S
  • Biofermen Private Limited

第 15 章:策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 17545

Global Lactose Intolerance Market was valued at USD 20.90 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.70% through 2030. The global lactose intolerance market has witnessed significant growth and evolution in recent years, driven by a rising prevalence of lactose intolerance worldwide and an increasing awareness of this condition among consumers. Lactose intolerance is a digestive disorder characterized by the body's inability to digest lactose, a sugar found in dairy products, leading to symptoms such as abdominal pain, diarrhea, and bloating.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 20.90 Billion
Market Size 2030USD 30.91 Billion
CAGR 2025-20306.70%
Fastest Growing SegmentPrimary Lactose Intolerance
Largest MarketNorth America

As a result, there has been a growing demand for lactose-free and dairy-free products, including milk alternatives, yogurt, and cheese substitutes, which has propelled the lactose intolerance market forward. One of the key drivers of this market is the increasing prevalence of lactose intolerance, which varies by region but is estimated to affect a significant portion of the global population. Factors such as genetics, ethnicity, and dietary habits contribute to the varying prevalence rates. Consequently, there is a growing need for diagnostic tests to accurately identify lactose intolerance, as well as a surge in demand for lactase supplements, which help individuals with lactose intolerance digest dairy products more comfortably. In addition to the rising prevalence of lactose intolerance, changing dietary preferences, and the growing trend of veganism and plant-based diets, have further fueled the demand for lactose-free alternatives. This has prompted food and beverage manufacturers to invest in research and development to create innovative dairy substitutes that cater to lactose-intolerant individuals, thereby expanding the lactose intolerance market. Furthermore, increased awareness and education regarding lactose intolerance have encouraged individuals to seek out suitable dietary options, leading to a surge in the consumption of lactose-free products. Consequently, the lactose intolerance market has witnessed substantial investments in product development, marketing, and distribution by both established players and emerging companies.

Key Market Drivers

Rising Prevalence of Lactose Intolerance

The rising prevalence of lactose intolerance has emerged as a significant driver behind the growth of the global lactose intolerance market. Lactose intolerance, a condition impairing the body's ability to digest lactose, affects approximately 65-70% of the global population, presenting a significant market consideration for the dairy and alternative food industries. Prevalence rates vary notably across demographics, with higher incidence observed among Asian, African, and Hispanic populations, underscoring the demand for lactose-free and dairy substitute products in these key consumer segments. Lactose intolerance is no longer a niche concern; instead, it has become a prevalent digestive disorder affecting millions of individuals worldwide. The condition's prevalence varies by region and ethnicity, but it is estimated that a substantial portion of the global population is lactose intolerant. Factors such as genetics, age, and dietary habits contribute to the development of lactose intolerance.

Key Market Challenges

Limited Diagnosis and Awareness

Lactose intolerance, a common digestive disorder affecting millions worldwide, is a condition characterized by the body's inability to properly digest lactose, a sugar found in dairy products. While it has gained recognition in recent years, limited diagnosis and awareness remain significant hurdles hindering the growth of the global lactose intolerance market.

One of the primary challenges facing the lactose intolerance market is the underdiagnosis of this condition. Many individuals who experience symptoms such as abdominal pain, bloating, diarrhea, and gas after consuming dairy products may not recognize these signs as indicators of lactose intolerance. Instead, they may attribute these symptoms to other factors, leading to a delay in diagnosis and treatment.

Key Market Trends

Plant-Based Diets and Veganism

Plant-based diets and veganism have emerged as significant drivers behind the growth of the global lactose intolerance market. These dietary trends, characterized by the avoidance of animal-derived products, including dairy, have created a substantial demand for lactose-free alternatives, which in turn have boosted the lactose intolerance market. Individuals adopting plant-based diets and embracing veganism often seek alternatives to traditional dairy products as they align with their ethical, environmental, and health-conscious beliefs. This shift in dietary preferences has led to a surge in the consumption of plant-based milk alternatives such as almond milk, soy milk, oat milk, and coconut milk, all of which are naturally devoid of lactose.

Moreover, veganism and plant-based diets have contributed to the expansion and diversification of the lactose-free product market. Manufacturers have responded to this trend by introducing a wide array of dairy-free options that cater not only to lactose-intolerant individuals but also to vegans and individuals looking to reduce their dairy consumption.

Key Market Players

  • Kshipra Biotech Private Limited
  • EMD Serono
  • Intoleran
  • MACLEODS
  • Merck KGaA
  • DSM
  • Johnson & Johnson Services, Inc
  • NOW Foods
  • Procter & Gamble
  • Chr. Hansen Holding A/S
  • Biofermen Private Limited

Report Scope:

In this report, the Global Lactose Intolerance Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Lactose Intolerance Market, By Type:

  • Primary
  • Secondary
  • Congenital
  • Developmental

Lactose Intolerance Market, By Diagnosis:

  • Hydrogen breath test
  • Glucose blood test
  • Stool acidity test

Lactose Intolerance Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Lactose Intolerance Market.

Available Customizations:

Global Lactose Intolerance Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Lactose Intolerance Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Primary, Secondary, Congenital, Developmental)
    • 5.2.2. By Diagnosis (Hydrogen breath test, Glucose blood test, Stool acidity test)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Lactose Intolerance Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Diagnosis
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Lactose Intolerance Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Diagnosis
    • 6.3.2. Canada Lactose Intolerance Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Diagnosis
    • 6.3.3. Mexico Lactose Intolerance Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Diagnosis

7. Europe Lactose Intolerance Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Diagnosis
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Lactose Intolerance Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Diagnosis
    • 7.3.2. United Kingdom Lactose Intolerance Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Diagnosis
    • 7.3.3. Italy Lactose Intolerance Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Diagnosis
    • 7.3.4. France Lactose Intolerance Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Diagnosis
    • 7.3.5. Spain Lactose Intolerance Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Diagnosis

8. Asia-Pacific Lactose Intolerance Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Diagnosis
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Lactose Intolerance Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Diagnosis
    • 8.3.2. India Lactose Intolerance Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Diagnosis
    • 8.3.3. Japan Lactose Intolerance Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Diagnosis
    • 8.3.4. South Korea Lactose Intolerance Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Diagnosis
    • 8.3.5. Australia Lactose Intolerance Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Diagnosis

9. South America Lactose Intolerance Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Diagnosis
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Lactose Intolerance Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Diagnosis
    • 9.3.2. Argentina Lactose Intolerance Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Diagnosis
    • 9.3.3. Colombia Lactose Intolerance Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Diagnosis

10. Middle East and Africa Lactose Intolerance Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Diagnosis
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Lactose Intolerance Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Lactose Intolerance Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Diagnosis
    • 10.3.3. UAE Lactose Intolerance Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Diagnosis

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Lactose Intolerance Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Kshipra Biotech Private Limited
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. EMD Serono
  • 14.3. Intoleran
  • 14.4. MACLEODS
  • 14.5. Merck KGaA
  • 14.6. DSM
  • 14.7. Johnson & Johnson Services, Inc
  • 14.8. NOW Foods
  • 14.9. Procter & Gamble
  • 14.10.Chr. Hansen Holding A/S
  • 14.11.Biofermen Private Limited

15. Strategic Recommendations

16. About Us & Disclaimer